|
|
324 S. Hyde Park Ave., Suite 350
Tampa, FL 33606 USA
phone:(813) 864-2558
fax:(813) 258-6912
|
|
| Symbol |
BVTI |
| Exchange |
OTCPK |
| Founded |
0 |
| Employees |
|
|
|
| www.biovest.com
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Manufacturer of biological drugs |
|
| Management |
| Francis E. O'Donnell, Jr. MD Chairman; Samuel S. Duffey, Esq. President and General Counsel; Mark Hirschel, Ph.D. Chief Scientific Officer; Alan Pearce, Chief Financial Officer; David D. Moser, Corporate Secretary; |
| |
|
|
|
|
|
|
|
| Keywords |
| non-hodgkin lymphoma, monoclonal antibodies, follicular lymphoma, chemotherapy, lymphocyte transplantation, oncology |
|
|
|
| Description |
|
Biovest International is a majority-owned subsidiary of Accentia Biopharmaceuticals
Inc., a vertically integrated specialty biopharmaceutical company with services to
commercialize targeted therapeutics, particularly for cancer. Biovest has a deep
foundation in the manufacture of biological drugs from small research scale quantities to
large volumes for Phase I and Phase II clinical material. In addition, Biovest International
develops, manufactures, and markets patented cell culture systems and equipment to
pharmaceutical, diagnostic and biotechnology companies, as well as leading research
institutions worldwide. For over 10 years the company has operated the National Cell
Culture Center (NCCC) under a grant from the National Institutes of Health. |
|
| Products / Services |
Biovest is currently conducting clinical trials on BiovaxID(tm), a cancer immunotherapy vaccine for Non-Hodgkin's Lymphoma.
|
|
| Market / Customers |
There are approximately 65,000 new cases of non-Hodgkin's lymphoma diagnosed each year in the US with a comparable number in Europe.
|
|
| Strategy |
A core mission of Biovest is to its our expertise in hollow fiber to advance personalized medicine and make it a reality. In addition to manufacturing Biovest's proprietary vaccine, the company is working with other biotechnology companies to provide manufacturing services for a variety of autologus treatments.
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members
